FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/12/2026
Back to search
Official data from USPTO
A
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079378177Class
1, 3, 5, 40, 42
Filing
79378177
Registration
7813350
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
04/03/2026
Trademark type
Combined
Nice classes
1, 3, 5, 40, 42
Filing date
04/13/2023
Registration date
06/03/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/03/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
27
Owner location
DE
Examiner
UKAOMA, ULOMA JANET
Law office
L80
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a stylized letter "A" comprised of a circle, an elongated semi-circle, a semi-circle, and a curved triangle.
Holders and representatives
Holders
Axplora Group GmbH
Representatives
B. Michelle Alvey Husch Blackwell LLP
Technical classification
Nice Classes
Class 1Class 3Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Unprocessed chemical productsunprocessed plasticsunprocessed polymersunprocessed artificial resins; biochemical catalystscatalysts for chemical and biochemical processescatalysts for use in the manufacture of industrial chemicals; chemical reagents for non-medical purposes; chemical additives for use in the manufacture of pharmaceuticalsagrochemicalscosmeticsfood productspolymers; chemical products as chemical synthesis intermediates for industrial purposes; active chemical ingredients for use in manufacture of pharmaceuticalsagrochemicalscosmeticsfood productspolymers; hemi synthesis productssemi-synthesized chemical products for use in biotechnological product development; fertilizers; chemical products as intermediates for the production of pharmaceuticalveterinarymedical and cosmetic active ingredients
Class 3
Purified essential oil extractsfor industrial use in the pharmaceuticalcosmeticsagrochemistryfoodpolymers industries
Class 5
Pharmaceuticalveterinarysanitary productssteroidsdiuretic preparationsanti-inflammatory preparationsdietary supplementsnutritional supplementsdiagnostic agents for medical purposes being visualization agents for use during colonoscopiescontraceptive preparationspreparations for the treatment of burnspharmaceutical preparations for the treatment of primary biliary cirrhosis in the nature of a cholelitholytic agentpharmaceutical preparations and substances for the treatment of metabolicendocrinemusculoskeletalcardiovascularcardiopulmonaryoncologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalimmune system related diseases and disorders; fungicidesherbicidesinsecticidespesticides
Class 40
Contract manufacturing of pharmaceutical and chemicals and their components for third parties; contract manufacturing of pharmaceuticalschemicals and biopharmaceuticals; custom manufacturing of vaccine adjuvantsvaccinesproteinssemi-synthetic moleculesconjugated moleculesnucleic acidspolysaccharidesother therapeutic biomolecules; custom manufacturing on a pilot and commercial scale of vaccine adjuvantsvaccinesproteinssemi-synthetic moleculesconjugated moleculesnucleic acidspolysaccharides and other therapeutic biomolecules; custom manufacturing in the nature of processing of functional food and food ingredients; custom manufacturing in the nature of processing on pilot and commercial scale of functional food and food ingredients; custom manufacturing of chemical productsactive pharmaceutical ingredients and synthetic intermediatesagrochemical active ingredients and synthetic intermediates; custom manufacturing on a pilot and commercial scale of chemical productsactive pharmaceutical ingredients and synthetic intermediatesagrochemical active ingredients and synthetic intermediates; custom manufacturing of chemicals through chemical syntheses; processing of biochemicals through the synthesis of biological products for customers in the foodchemicalagriculturalveterinary and pharmaceutical industries; custom synthesis of intermediate products in the nature of intermediate organic products for industrial purposes for the foodchemicalagriculturalveterinarypharmaceutical industries; contract manufacturing of hazardous products being glycerol trinitrateazidesexplosives and other industrial chemicals for third parties; contract custom manufacturing of substitution aromates and chiral molecules for use in synthesis of products for others for third parties; preparation of galenic formulations for otherscustom manufacture of pharmaceuticals by pharmaceutical compounders
Class 42
Providing quality controlanalytic control and authentication services for others; conducting of technical feasibility studies; technical and scientific research and development on new and existing productsnotably for the foodchemicalagriculturalveterinarypharmaceutical industries; scientific research in the field of galenic formsspecifically for others
Publications
History of USPTO decisions and trademark events.
38 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
01/05/2026
XXCR
GENERIC MADRID TRANSACTION CREATED
01/05/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/03/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/03/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
06/03/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/15/2025
PUBO
PUBLISHED FOR OPPOSITION
04/15/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/09/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/17/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/01/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/10/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/08/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/07/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/07/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/19/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/13/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/07/2024
GNRT
NON-FINAL ACTION E-MAILED
08/07/2024
CNRT
NON-FINAL ACTION WRITTEN
08/07/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
06/10/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/10/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
06/10/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/10/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/02/2024
RFNP
REFUSAL PROCESSED BY IB
10/25/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
10/06/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/03/2023
RFRR
REFUSAL PROCESSED BY MPU
10/02/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/14/2023
CNRT
NON-FINAL ACTION WRITTEN
09/13/2023
MAFR
APPLICATION FILING RECEIPT MAILED
09/12/2023
DOCK
ASSIGNED TO EXAMINER
09/09/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/08/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/07/2023
Continuous trademark protection
Get notified about every new filing that threatens A or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.